Results 171 to 180 of about 751,516 (267)

Differential roles of dopamine D1 and D2 receptors in pain modulation: a review. [PDF]

Front Neurol
Huang M, Li X, Miao Y, Mao W, Xu C, Gu M.   +5 more
europepmc   +1 more source

Xanomeline and Trospium Chloride: Mechanism of Action, Clinical, and Translational Science

Clinical and Translational Science, Volume 19, Issue 9, September 2026.
ABSTRACT Xanomeline‐trospium chloride (Cobenfy, formerly KarXT) is a first‐in‐class, oral central M1/M4 muscarinic receptor agonist approved for the treatment of schizophrenia in adults. Cobenfy represents a paradigm shift by avoiding direct dopamine D2 receptor blockade and thus significantly reduces the burden of metabolic, extrapyramidal, and ...
Samantha Avila, Ingrid L. Chen
wiley   +1 more source

Characterization of [³H]MCL-524, a Potent Dopamine D₂ ^high Receptor Agonist. [PDF]

ACS Omega
Subburaju S, Sromek AW, Seeman P, Neumeyer JL.   +3 more
europepmc   +1 more source

ACTH suppression and adverse effects of cabergoline in horses with pituitary pars intermedia dysfunction

Equine Veterinary Education, Volume 38, Issue 9, Page e622-e630, September 2026.
Summary Background The diagnosis and management of pituitary pars intermedia dysfunction (PPID) in horses includes evaluating abnormal plasma concentrations of adrenocorticotrophic hormone (ACTH). Treatment commonly includes the oral dopamine agonist pergolide mesylate, which suppresses the pathologic overproduction of ACTH.
A. Bracken, H. Tyra, M. Vetter, K. Kiger, S. Rao, L. Bass   +5 more
wiley   +1 more source

Dopamine Receptor Modulation in Co-Occurring Disorders: Potential of Cariprazine and D3 Receptor Activity. [PDF]

J Dual Diagn
Lynch ST, Mariani JJ, Levin FR.
europepmc   +1 more source

Tardive Dyskinesia in Patients Receiving Continuous Versus Intermittent Oral Metoclopramide: A Retrospective Real World Study

Neurogastroenterology &Motility, Volume 38, Issue 9, September 2026.
Continuous MCP dosing was associated with higher TD prevalence and earlier onset. Intermittent dosing, despite longer cumulative exposure, was associated with lower TD risk. These findings suggest that intermittent regimens may offer a safer MCP therapeutic strategy. ABSTRACT Background Tardive dyskinesia (TD) is an often irreversible movement disorder
Pierantonio Russo, Ramaa Nathan, Michael Camilleri   +2 more
wiley   +1 more source

Dopaminergic-Nitrergic Microcircuitry in the Paraventricular Nucleus: Translational Relevance for Psychiatric Practice. [PDF]

Anat Histol Embryol
Kong SS, Wei LC.
europepmc   +1 more source

Dopaminergic genetic variation and response to social comparative feedback when learning a motor sequence task. [PDF]

PLoS One
Lewis AF, Bohnenkamp R, Stewart JC.
europepmc   +1 more source

Striatal remodeling in Parkinson disease. [PDF]

J Pharmacol Exp Ther
Emerson SD, Sugimoto C, Honeycutt SC, Calipari ES.   +3 more
europepmc   +1 more source

Identification of novel peripherally restricted risperidone-like dopamine D2 receptor antagonists for prolactin-mediated neuroprotection through a multi-stage in silico screening. [PDF]

PLoS One
Kim S, Jo WH, Cha JO, Kim MS.
europepmc   +1 more source